Imaging artery plaque inflammation with a fluorescent dye
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a special dye that lights up inflammation in artery plaques. During your planned surgery, the dye will be applied to the removed plaque to see if it can help identify dangerous areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe narrowing or bulging in the arteries of your neck or legs and are having surgery to fix it.
- You are 18 years or older.
- You are able to understand and agree to the study.
- For women who could become pregnant: a negative pregnancy test is required.
- Your kidney function must be normal or only mildly reduced.
- You cannot have a history of allergy to contrast dye or to a substance called polyethylene glycol (PEG).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies plaque activity in leg arteries using a new imaging method to understand artery disease better. It may help people with peripheral artery disease get more targeted treatment.
This trial looks at specific markers in the blood to better understand unstable plaque in the carotid artery. It may help doctors identify which patients are at higher risk for stroke.
This study uses a heart stress ultrasound test, plus a contrast dye, to look for new blood vessel growth inside carotid plaque (the buildup in neck arteries). It may help doctors better judge the risk of stroke and determine which people need closer care.
This Phase 1 study tests whether a special PET scan can detect a specific inflammation signal (CCR2) in atherosclerosis—fatty plaque buildup in blood vessels. It may help future doctors better see which plaques are more inflamed and potentially more dangerous.
This trial uses advanced ultrasound techniques to get detailed images of carotid artery plaque. It aims to better understand plaque characteristics, which could help guide treatment decisions for people with significant narrowing in their carotid artery.
This trial tests a new contrast agent called ABL-101 that lights up on a special MRI scan to show inflammation in fatty deposits (plaque) in the carotid arteries. If you are scheduled for surgery to remove plaque from your carotid artery (carotid endarterectomy), this study may help doctors better understand what the plaque is made of and how inflamed it is.
Hear when a new Carotid Artery Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.